The CRC Blueprint

My scientific approach to my own cancer – shared with you.

China

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers

Phase 2 · 220 people · 55 sites in 13 countries · Recruiting now

August 7, 2026
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC

Phase 3 · randomised · 204 people · 1 site in China · Recruiting now

August 7, 2026
Radiotherapy + Systemic Therapy as Conversion Therapy for pMMR/MSS T4M0 Colon Cancer（Neo-Color）

Phase 2 · randomised · 128 people · 1 site in China · Recruiting now

August 7, 2026
PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

Phase 2 · randomised · 100 people · 11 sites in China · Recruiting now

August 7, 2026
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Phase 2 · randomised · 768 people · 105 sites in 10 countries · Recruiting now

August 7, 2026
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Phase 2 · randomised · 80 people · 76 sites in 12 countries · Recruiting now

August 7, 2026
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Phase 3 · randomised · 800 people · 285 sites in 17 countries · Recruiting now

August 7, 2026
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

Phase 2 · 225 people · 53 sites in 11 countries · Recruiting now

August 7, 2026
IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer

Phase 3 · randomised · 550 people · 2 sites in China · Opening soon

August 7, 2026
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation

Phase 3 · randomised · 461 people · 419 sites in 32 countries · Running, not taking new patients

August 7, 2026